All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention Sky Impact Capital, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.5 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Oncare
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention Sky Impact Capital, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.5 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. We currently track 1 Startup story that mention Oncare, all published on February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Oncare. Shared-story counts are live from our verified record — not editorial picks.
Delhi-based oncology startup Oncare has raised ₹27 crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will fuel the company's expansion from its current Delhi NCR hub into metro, Tier-2, and Tier-3 cities nationwide.
Oncare is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.